Baillie Gifford & Co’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3M Sell
643,675
-3,195,952
-83% -$70.7M 0.01% 193
2026
Q1
$89.5M Buy
3,839,627
+128,287
+3% +$4M 0.09% 126
2025
Q4
$164M Sell
3,711,340
-138,422
-4% -$7.77M 0.14% 109
2025
Q3
$282M Sell
3,849,762
-84,269
-2% -$5.49M 0.21% 83
2025
Q2
$241M Sell
3,934,031
-189,143
-5% -$10.6M 0.18% 89
2025
Q1
$239M Sell
4,123,174
-820,568
-17% -$51.8M 0.21% 79
2024
Q4
$264M Sell
4,943,742
-415,493
-8% -$20.3M 0.2% 81
2024
Q3
$234M Sell
5,359,235
-537,291
-9% -$17.9M 0.17% 91
2024
Q2
$165M Sell
5,896,526
-319,793
-5% -$8.44M 0.13% 107
2024
Q1
$167M Sell
6,216,319
-83,184
-1% -$2.37M 0.13% 102
2023
Q4
$177M Sell
6,299,503
-356,739
-5% -$8.43M 0.14% 104
2023
Q3
$141M Buy
6,656,242
+57,078
+0.9% +$1.56M 0.13% 108
2023
Q2
$225M Buy
6,599,164
+2,210,439
+50% +$73.6M 0.19% 92
2023
Q1
$142M Buy
4,388,725
+3,268,078
+292% +$108M 0.13% 107
2022
Q4
$37.6M Buy
1,120,647
+402,245
+56% +$12.3M 0.04% 156
2022
Q3
$21.7M Buy
+718,402
New +$26.3M 0.02% 181

Other funds holding DOCS

Baillie Gifford & Co's DOCS Position: Q2 2026 in Review

Baillie Gifford & Co reduced its Doximity (DOCS) stake by 83% in Q2 2026, selling an estimated $70.7M and leaving 643,675 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #193.

Baillie Gifford & Co first reported a position in DOCS in Q3 2022 and has held it in 16 quarters since. The position peaked at $282M in Q3 2025. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Baillie Gifford & Co held 643,675 shares of Doximity worth $13.3M as of Q2 2026.
  • Baillie Gifford & Co sold 3,195,952 Doximity shares in Q2 2026, an estimated $70.7M.
  • Doximity made up 0.01% of Baillie Gifford & Co's portfolio in Q2 2026, its #193 holding.
  • Baillie Gifford & Co first reported a position in Doximity in Q3 2022 and has held it in 16 quarters since.
  • Baillie Gifford & Co's Doximity position peaked at $282M in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.